PLENARY SESSIONS
Join us for premier sessions highlighting the latest advances in neuroscience presented by some of the most cutting-edge and well-known thought leaders in the field of neurology. Many of the sessions will have opportunities to engage with the speakers immediately following with fireside chats.
Join for Fireside Chats After Plenary Sessions Participate in live, moderated fireside chats with speakers immediately following the Frontiers in Neuroscience, Presidential, Contemporary Clinical Issues, Clinical Trials, and Controversies in Neurology Plenary Sessions. You are encouraged to submit your questions during the fireside chats for the opportunity to have speakers respond live.
Walter J. Koroshetz, MD, FAAN, Bethesda, MD
Anthony S. Fauci, MD, Bethesda, MD
Keynote Address
Hot Topics: Neuro-COVID Plenary Session Saturday, April 17 5:00 p.m.–7:00 p.m. ET For the first time, the 2021 Hot Topics Plenary Session will focus entirely on one important issue, the global COVID-19 pandemic. Join the keynote address with Walter J. Koroshetz, MD, FAAN, and Anthony S. Fauci, MD, who have been at the forefront of the public health crisis. Four outstanding speakers will then summarize their COVID-19related research findings and describe the clinical implications of their work.
Presidential Plenary Session Sunday, April 18 10:00 a.m.–1:00 p.m. ET This session features the AAN’s premier lecture awards for clinically relevant research and a presentation by a leading lecturer. Top researchers speak on some of the most significant findings in neurology in 2021. AAN President James C. Stevens, MD, FAAN, will kick off the session with a presentation of the President’s Award and Presidential Lecture. After that, tune in for a live address from AAN Chief Executive Officer Mary Post, MBA, CAE, followed by a few words from AAN President Elect Orly Avitzur, MD, MBA, FAAN.
Session moderators will then introduce this year's list of superb lecturers. Followed by a live fireside chat from 1:00 p.m.–2:00 p.m. ET. Contemporary Clinical Issues Plenary Session Monday, April 19 10:00 a.m.–12:30 p.m. ET This session highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. The first three topics will be introduced by presenters followed by a commentary from the discussant. The second half of the session will feature standalone talks on various topics. Followed by a live fireside chat from 12:30 p.m.–1:30 p.m. ET. Clinical Trials Plenary Session Tuesday, April 20 10:00 a.m.–12:30 p.m. ET This session covers important clinical topics identified from other society meetings that affect patient care. The latest updates within several clinical trials conducted over the course of the last year will be presented. Followed by a live fireside chat from 12:30 p.m.–1:30 p.m. ET. Controversies in Neurology Plenary Session Wednesday, April 21 10:00 a.m.–12:30 p.m. ET This session features experts discussing the most current and controversial issues in neuroscience. Tune in for a scholarly debate between two expert speakers, each advocating for one side of a single topic, followed by a rebuttal. Followed by a live fireside chat from 12:30 p.m.–1:30 p.m. ET. Neurology Year in Review Plenary Session Thursday, April 22 10:00 a.m.–12:30 p.m. ET This session looks back at the past year of research, highlighting some of the most relevant strides made in neurology subspecialties, including movement disorders, stroke, and headache. One speaker will examine how we diversify the neurology workforce. AAN.com/21AM
23
PLENARY SESSIONS
Frontiers in Neuroscience Plenary Session Saturday, April 17 10:00 a.m.–12:00 p.m. ET This plenary session features basic and translational research related to clinical issues of importance. Hear from five outstanding speakers as they summarize their recent research finding and dive into the clinical implications of the results. Followed by a live fireside chat from 12:00 p.m.–1:00 p.m. ET.
